Why the study?
Does peritoneal dialysis improve markers of arterial stiffness, oxidative stress, and inflammation compared to hemodialysis in incident end-stage kidney disease patients?
Does peritoneal dialysis improve markers of arterial stiffness, oxidative stress, and inflammation compared to hemodialysis in incident end-stage kidney disease patients?
This study protocol describes a prospective observational trial to evaluate whether peritoneal dialysis has a more favorable impact on arterial stiffness, oxidative stress, and inflammation compared to hemodialysis in incident end-stage kidney disease patients.
No takes yet. Share an insight, caveat, or question.
Should not alter ESKD modality selection yet; this observational protocol leaves open comparative effects on arterial stiffness and inflammation.
Fassett et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: